References
- Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's disease. Lancet. 1990;335(8697):1078–80.
- The International Criteria for Behcet's Disease (ICBD). A collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338–47.
- Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med. 1999;341(17):1284–91.
- Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, et al. Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet. 2013;45(2):202–7.
- Takeuchi M, Mizuki N, Meguro A, Ombrello MJ, Kirino Y, Satorius C, et al. Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behcet's disease susceptibility. Nat Genet. 2017;49(3):438–43.
- Kirino Y, Ideguchi H, Takeno M, Suda A, Higashitani K, Kunishita Y, et al. Continuous evolution of clinical phenotype in 578 Japanese patients with Behcet's disease: a retrospective observational study. Arthritis Res Ther. 2016;18(1):217.
- Pehlivan M, Kurtuncu M, Tuzun E, Shugaiv E, Mutlu M, Eraksoy M, et al. The comparison of socio-economic conditions and personal hygiene habits of neuro-Behcet's disease and multiple sclerosis patients. Int J Hyg Environ Health. 2011;214(4):335–7.
- Mumcu G, Niazi S, Stewart J, Hagi-Pavli E, Gokani B, Seoudi N, et al. Oral health and related quality of life status in patients from UK and Turkey: a comparative study in Behcet's disease. J Oral Pathol Med. 2009;38(5):406–9.
- Aramaki K, Kikuchi H, Hirohata S. HLA-B51 and cigarette smoking as risk factors for chronic progressive neurological manifestations in Behcet's disease. Mod Rheumatol. 2007;17(1):81–2.
- Ishido T, Horita N, Takeuchi M, Kawagoe T, Shibuya E, Yamane T, et al. Clinical manifestations of Behcet's disease depending on sex and age: results from Japanese nationwide registration. Rheumatology. 2017;56(11):1918–27.
- Suwa A, Horita N, Ishido T, Takeuchi M, Kawagoe T, Shibuya E, et al. The ocular involvement did not accompany with the genital ulcer or the gastrointestinal symptoms at the early stage of Behcet's disease. Mod Rheumatol. 2019;29(2):357–62.
- Suzuki T, Horita N, Takeuchi M, Ishido T, Mizuki Y, Mizuki R, et al. Clinical features of early-stage possible Behcet's disease patients with a variant-type major organ involvement in Japan. Mod Rheumatol. 2019;29(4):640–6.
- Japanese Ministry of Health, Labour and Welfare. Statutory intractable diseases. Implemented on January 1st, 2015. [Japanese]. Available from: http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000062437.html [last accessed 1 Aug, 2019].
- Japan Intractable Diseases Information Center, Behcet Disease. [Japanese]. Avilable from: www.nanbyou.or.jp/entry/330 [last accessed 1 Aug, 2019].
- Japanese Ministry of Health, Labour and Welfare. Ethical Guidelines for Medical and Health Research Involving Human Subjects. 2015. Available from: http://www.lifescience.mext.go.jp/files/pdf/n1500_01.pdf#search='Ethics+Review+Procedures+concerning+Research+with+Human+Subjects+published+in+2015+by+Ministry+of+Health%2C+Labour+and+Welfare%2C+Japan'. [last accessed 1 Aug, 2019].
- Maldini C, Lavalley MP, Cheminant M, de Menthon M, Mahr A. Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatology. 2012;51(5):887–900.
- Horie Y, Meguro A, Ohta T, Lee EB, Namba K, Mizuuchi K, et al. HLA-B51 carriers are susceptible to ocular symptoms of Behcet disease and the association between the two becomes stronger towards the east along the Silk Road: A literature survey. Ocul Immunol Inflamm. 2017;25(1):37–40.
- Nishiyama M, Nakae K, Umehara T. A study of familial occurrence of Behçet's disease with and without ocular lesions. Jpn J Ophthalmol. 2001;45(3):313–6.
- Arimoto J, Endo H, Kato T, Umezawa S, Fuyuki A, Uchiyama S, et al. Clinical value of capsule endoscopy for detecting small bowel lesions in patients with intestinal Behcet's disease. Dig Endosc. 2016;28(2):179–85.
- de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009;61(10):1287–96.
- Kaburaki T, Takamoto M, Numaga J, Kawashima H, Araie M, Ohnogi Y, et al. Genetic association of HLA-A*2601 with ocular Behçet's disease in Japanese patients. Clin Exp Rheumatol. 2010;28(4 Suppl 60):S39–S44.